Logo image of EDBL

EDIBLE GARDEN AG INC (EDBL) Stock Fundamental Analysis

USA - NASDAQ:EDBL - US28059P4028 - Common Stock

1.89 USD
+0.04 (+2.41%)
Last: 10/3/2025, 8:00:01 PM
Fundamental Rating

3

Overall EDBL gets a fundamental rating of 3 out of 10. We evaluated EDBL against 89 industry peers in the Food Products industry. EDBL has a bad profitability rating. Also its financial health evaluation is rather negative. EDBL is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

EDBL had negative earnings in the past year.
EDBL had a negative operating cash flow in the past year.
EDBL had negative earnings in each of the past 5 years.
EDBL had a negative operating cash flow in each of the past 5 years.
EDBL Yearly Net Income VS EBIT VS OCF VS FCFEDBL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -5M -10M

1.2 Ratios

EDBL has a worse Return On Assets (-120.18%) than 94.38% of its industry peers.
The Return On Equity of EDBL (-157.99%) is worse than 83.15% of its industry peers.
Industry RankSector Rank
ROA -120.18%
ROE -157.99%
ROIC N/A
ROA(3y)-152.37%
ROA(5y)-135.76%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
EDBL Yearly ROA, ROE, ROICEDBL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 1K 2K 3K

1.3 Margins

With a Gross Margin value of 11.72%, EDBL is not doing good in the industry: 62.92% of the companies in the same industry are doing better.
EDBL's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for EDBL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 11.72%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y39.34%
GM growth 5YN/A
EDBL Yearly Profit, Operating, Gross MarginsEDBL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -20 -40 -60 -80 -100

3

2. Health

2.1 Basic Checks

EDBL does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, EDBL has more shares outstanding
EDBL has a better debt/assets ratio than last year.
EDBL Yearly Shares OutstandingEDBL Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 200K 400K 600K 800K 1M
EDBL Yearly Total Debt VS Total AssetsEDBL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

EDBL has an Altman-Z score of -3.45. This is a bad value and indicates that EDBL is not financially healthy and even has some risk of bankruptcy.
EDBL has a worse Altman-Z score (-3.45) than 85.39% of its industry peers.
EDBL has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.02, EDBL belongs to the top of the industry, outperforming 82.02% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z -3.45
ROIC/WACCN/A
WACC6.97%
EDBL Yearly LT Debt VS Equity VS FCFEDBL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 -5M -10M

2.3 Liquidity

EDBL has a Current Ratio of 1.49. This is a normal value and indicates that EDBL is financially healthy and should not expect problems in meeting its short term obligations.
EDBL has a Current ratio of 1.49. This is comparable to the rest of the industry: EDBL outperforms 49.44% of its industry peers.
EDBL has a Quick Ratio of 1.14. This is a normal value and indicates that EDBL is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.14, EDBL is in the better half of the industry, outperforming 68.54% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.49
Quick Ratio 1.14
EDBL Yearly Current Assets VS Current LiabilitesEDBL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2M 4M 6M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 96.71% over the past year.
The Revenue for EDBL has decreased by -16.60% in the past year. This is quite bad
The Revenue has been growing by 9.66% on average over the past years. This is quite good.
EPS 1Y (TTM)96.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%78.25%
Revenue 1Y (TTM)-16.6%
Revenue growth 3Y9.66%
Revenue growth 5YN/A
Sales Q2Q%-26.29%

3.2 Future

EDBL is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 41.28% yearly.
Based on estimates for the next years, EDBL will show a very strong growth in Revenue. The Revenue will grow by 22.35% on average per year.
EPS Next Y99.17%
EPS Next 2Y41.28%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year24.75%
Revenue Next 2Y22.35%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
EDBL Yearly Revenue VS EstimatesEDBL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 5M 10M 15M 20M
EDBL Yearly EPS VS EstimatesEDBL Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 -5K -10K -15K -20K -25K

1

4. Valuation

4.1 Price/Earnings Ratio

EDBL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year EDBL is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EDBL Price Earnings VS Forward Price EarningsEDBL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EDBL Per share dataEDBL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -10 -20 -30

4.3 Compensation for Growth

EDBL's earnings are expected to grow with 41.28% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.28%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for EDBL!.
Industry RankSector Rank
Dividend Yield N/A

EDIBLE GARDEN AG INC

NASDAQ:EDBL (10/3/2025, 8:00:01 PM)

1.89

+0.04 (+2.41%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)08-14 2025-08-14/bmo
Earnings (Next)11-11 2025-11-11
Inst Owners0.74%
Inst Owner Change0%
Ins Owners0.15%
Ins Owner Change0.13%
Market Cap5.52M
Analysts82.86
Price Target8.16 (331.75%)
Short Float %7.57%
Short Ratio1.34
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-375.84%
Min EPS beat(2)-771.75%
Max EPS beat(2)20.08%
EPS beat(4)1
Avg EPS beat(4)-203.13%
Min EPS beat(4)-771.75%
Max EPS beat(4)20.08%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-30.71%
Min Revenue beat(2)-31.17%
Max Revenue beat(2)-30.25%
Revenue beat(4)0
Avg Revenue beat(4)-25.29%
Min Revenue beat(4)-31.75%
Max Revenue beat(4)-7.98%
Revenue beat(8)1
Avg Revenue beat(8)-13.97%
Revenue beat(12)4
Avg Revenue beat(12)-7.39%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.45
P/FCF N/A
P/OCF N/A
P/B 0.33
P/tB 0.34
EV/EBITDA N/A
EPS(TTM)-35.64
EYN/A
EPS(NY)-1.54
Fwd EYN/A
FCF(TTM)-3.39
FCFYN/A
OCF(TTM)-3.3
OCFYN/A
SpS4.22
BVpS5.68
TBVpS5.58
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -120.18%
ROE -157.99%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 11.72%
FCFM N/A
ROA(3y)-152.37%
ROA(5y)-135.76%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y39.34%
GM growth 5YN/A
F-Score4
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 27.96%
Cap/Sales 2.18%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.49
Quick Ratio 1.14
Altman-Z -3.45
F-Score4
WACC6.97%
ROIC/WACCN/A
Cap/Depr(3y)102.93%
Cap/Depr(5y)69.29%
Cap/Sales(3y)9.02%
Cap/Sales(5y)5.97%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)96.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%78.25%
EPS Next Y99.17%
EPS Next 2Y41.28%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-16.6%
Revenue growth 3Y9.66%
Revenue growth 5YN/A
Sales Q2Q%-26.29%
Revenue Next Year24.75%
Revenue Next 2Y22.35%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-10.98%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y15.69%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-5.23%
OCF growth 3YN/A
OCF growth 5YN/A